Vanguard Group Discloses Interest in Spire Healthcare

The Vanguard Group, Inc. has disclosed its interest in the securities of Spire Healthcare Group plc as outlined in Form 8.3 under the Takeover Code. The disclosure highlights that Vanguard possesses 14,275,149 ordinary shares, representing a 3.54% interest in the healthcare company as of 27 July 2026.

The document specifies that no additional parties are involved in the disclosure aside from Spire Healthcare. It also records a purchase of 858 shares and a sale of 441 shares, both transacted at 2.32 GBP per unit. No cash-settled or stock-settled derivative positions are reported, nor any other inducements or agreements related to options or derivatives.

The disclosure, dating from 28 July 2026, appears devoid of further attachments, indicating that Vanguard's positions are solely within the realm of ordinary shares without additional strategic maneuvers.